Kozlowska Urszula, Krawczenko Agnieszka, Futoma Katarzyna, Jurek Tomasz, Rorat Marta, Patrzalek Dariusz, Klimczak Aleksandra
Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw 53-114, Poland.
Department of Forensic Medicine, Wroclaw Medical University, Wroclaw 50-345, Poland.
World J Stem Cells. 2019 Jun 26;11(6):347-374. doi: 10.4252/wjsc.v11.i6.347.
Mesenchymal stromal/stem cells (MSCs) constitute a promising tool in regenerative medicine and can be isolated from different human tissues. However, their biological properties are still not fully characterized. Whereas MSCs from different tissue exhibit many common characteristics, their biological activity and some markers are different and depend on their tissue of origin. Understanding the factors that underlie MSC biology should constitute important points for consideration for researchers interested in clinical MSC application.
To characterize the biological activity of MSCs during longterm culture isolated from: bone marrow (BM-MSCs), adipose tissue (AT-MSCs), skeletal muscles (SM-MSCs), and skin (SK-MSCs).
MSCs were isolated from the tissues, cultured for 10 passages, and assessed for: phenotype with immunofluorescence and flow cytometry, multipotency with differentiation capacity for osteo-, chondro-, and adipogenesis, stemness markers with qPCR for mRNA for Sox2 and Oct4, and genetic stability for p53 and c-Myc; 27 bioactive factors were screened using the multiplex ELISA array, and spontaneous fusion involving a co-culture of SM-MSCs with BM-MSCs or AT-MSCs stained with PKH26 (red) or PKH67 (green) was performed.
All MSCs showed the basic MSC phenotype; however, their expression decreased during the follow-up period, as confirmed by fluorescence intensity. The examined MSCs express CD146 marker associated with proangiogenic properties; however their expression decreased in AT-MSCs and SM-MSCs, but was maintained in BM-MSCs. In contrast, in SK-MSCs CD146 expression increased in late passages. All MSCs, except BM-MSCs, expressed PW1, a marker associated with differentiation capacity and apoptosis. BM-MSCs and AT-MSCs expressed stemness markers Sox2 and Oct4 in long-term culture. All MSCs showed a stable p53 and c-Myc expression. BM-MSCs and AT-MSCs maintained their differentiation capacity during the follow-up period. In contrast, SK-MSCs and SM-MSCs had a limited ability to differentiate into adipocytes. BM-MSCs and AT-MSCs revealed similarities in phenotype maintenance, capacity for multilineage differentiation, and secretion of bioactive factors. Because AT-MSCs fused with SM-MSCs as effectively as BM-MSCs, AT-MSCs may constitute an alternative source for BM-MSCs.
Long-term culture affects the biological activity of MSCs obtained from various tissues. The source of MSCs and number of passages are important considerations in regenerative medicine.
间充质基质/干细胞(MSCs)是再生医学中一种很有前景的工具,可从不同的人体组织中分离得到。然而,它们的生物学特性仍未完全明确。虽然来自不同组织的MSCs表现出许多共同特征,但其生物学活性和一些标志物存在差异,且取决于其组织来源。了解MSCs生物学的潜在因素,对于对临床应用MSCs感兴趣的研究人员来说,应是重要的考虑要点。
对从骨髓(BM - MSCs)、脂肪组织(AT - MSCs)、骨骼肌(SM - MSCs)和皮肤(SK - MSCs)中分离的MSCs进行长期培养,以表征其生物学活性。
从组织中分离MSCs,培养10代,并进行如下评估:通过免疫荧光和流式细胞术检测表型;通过向成骨、成软骨和成脂肪分化的能力评估多能性;通过qPCR检测Sox2和Oct4 mRNA的干标志物;通过检测p53和c - Myc评估遗传稳定性;使用多重ELISA阵列筛选27种生物活性因子;对用PKH26(红色)或PKH67(绿色)染色的SM - MSCs与BM - MSCs或AT - MSCs进行共培养,以检测自发融合情况。
所有MSCs均表现出基本的MSCs表型;然而,通过荧光强度证实,在随访期间其表达下降。所检测的MSCs表达与促血管生成特性相关的CD146标志物;然而,其在AT - MSCs和SM - MSCs中的表达下降,但在BM - MSCs中保持稳定。相反,在SK - MSCs中,CD146表达在传代后期增加。除BM - MSCs外,所有MSCs均表达与分化能力和细胞凋亡相关的PW1标志物。BM - MSCs和AT - MSCs在长期培养中表达干标志物Sox2和Oct4。所有MSCs均表现出稳定的p53和c - Myc表达。BM - MSCs和AT - MSCs在随访期间保持其分化能力。相反,SK - MSCs和SM - MSCs向脂肪细胞分化的能力有限。BM - MSCs和AT - MSCs在表型维持、多谱系分化能力和生物活性因子分泌方面表现出相似性。由于AT - MSCs与SM - MSCs的融合效果与BM - MSCs相同,因此AT - MSCs可能是BM - MSCs的替代来源。
长期培养会影响从各种组织中获得的MSCs的生物学活性。MSCs的来源和传代数是再生医学中的重要考虑因素。